Affective Psychosis, Bipolar
7
0
0
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
43%
3 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (7)
Non-interventional Study of Ziprasidone in the Treatment of Bipolar and Schizoaffective Disorders.
Management of my Bipolarity Intervention in Bipolar Disorder Patients
Smoking Cessation for Veterans With Severe and Persistent Mental Illness
Duration of Untreated Psychosis (DUP) and Pathways to Care in Nordland
A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder
Phase III/Seroquel SR Bipolar Depression Monotherapy - US
Phase 3 /Seroquel SR Acute Mania Monotherapy - US